Open AccessEfficacy of montelukast for the treatment of pediatric allergic purpura
Author(s) -
Liping Bai,
Jing Yu,
Yongkun Sun,
Jiumei Wang
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000017239
Subject(s) - montelukast , medicine , cinahl , medline , data extraction , intensive care medicine , purpura (gastropod) , asthma , psychiatry , political science , psychological intervention , law , ecology , biology
Background: This study aims to evaluate the efficacy and safety of montelukast for the treatment of patients with pediatric allergic purpura (PAP). Methods: We will retrieve the following electronic databases from inception to the present: MEDILINE, Embase, CENTRAL, CINAHL, AMED, Chinese Biomedical Literature Database, China National Knowledge Infrastructure Database, Wanfang, and VIP database without language limitation. Two authors will carry out study selection, data extraction, and quality evaluation independently. RevMan V5.3 software will be used for statistical software. Results: This study will summarize high-quality evidence-based medicine to evaluate the efficacy and safety of montelukast for the treatment of PAP. Conclusion: This study will provide strong evidence to determine whether montelukast is an effective and safety treatment for PAP. Systematic review registration: PROSPERO CRD42019145472.